pmr.cuni.cz/Data/Files/PragueMedicalReport/pmr_110_2009_03/pmr2009a0025.pdf
Finasteride Treatment and Neuroactive Steroid Formation
Dušková M., Hill M., Hanuš M., Matoušková M., Stárka L.
Institute of Endocrinology, Prague, Czech Republic;
Urocenrum, Prague, Czech Republic
Abstract: Finasteride is the 5α-reductase inhibitor that received clinical approval
for the treatment of human benign prostate hyperplasia and androgenetic
alopecia. The 5α-reductase is enzyme responsible for the reduction of
testosterone to dihydrostestosterone, progesterone to dihydroprogesterone and
deoxycorticosterone to dihydrodeoxycorticosterone, steroids modulating the action
of γ-aminobutyric acid on GABA receptors. These neuroactive steroids possess
anticonvulsant, antidepressant and anxiolytic effects. The objective of the study
was to determine the effect of finasteride therapy on a broad steroid spectrum in
men with benign prostate hyperplasia. A group of 20 men with benign prostate
hyperplasia was involved in the present study. Finasteride in the daily dose
of 5 mg/day was administrated for 4 months. In all individuals, their hormonal
profile of steroid hormones was determined before and after 4 months lasting
finasteride treatment. Finasteride treatment resulted in a significant decrease
all α-reduced and increase of most 5β-reduced metabolites of testosterone and
progesterone as well as in an increase of 7α-hydoxyderivatives, which are known as
neuroactive steroids acting by modulation of GABAA and NMAD receptors in the
brain. In the course of finasteride treatment the decrease of the concentration of
circulating steroids with known inhibitory activity on GABA-ergic excitation in the
brain is very probably an important factors contributing to the development of the
symptoms of depression seen in some isolated cases of finasteride administration.
Oscar (Mew?) - would you mind pulling the original post? I think it will add confusion; I can pull up some more studies showing P effects on neurosteroid production if that would be helpful.